BioSpace News Archive

xD Bio Inc. announced that the National Human Genome Research Institute, part of the National Institutes of Health, has awarded the company $149,959 over 6 months for the first phase of a Small Business Technology Transfer grant.

Mallinckrodt plc (NYSE: MNK) announced (1) the early results of the previously announced offers by its wholly owned subsidiaries, Mallinckrodt International Finance S.A. and Mallinckrodt CB LLC (the “Issuers”) to Eligible Holders (as defined below) to exchange (the “Exchange Offers”) certain outstanding notes

CStone Pharmaceuticals announced that the first patient has been dosed in the Phase I bridging registrational study of ivosidenib in China.

Technavio has announced its latest market research report titled global tumor profiling market 2020-2024.

Intersect ENT, Inc. (NASDAQ: XENT) today announced that management will participate in the 31st Annual Piper Jaffray Healthcare Conference on December 4 at the Lotte New York Palace Hotel in New York City, and will present in a session at 4:30 pm ET.

Technavio has announced its latest market research report titled global infusion therapy devices market 2019-2023.

Venus Concept Inc. announced that it has received a medical device license issued by Health Canada to market Venus Bliss™, a medical aesthetic platform that offers a comprehensive solution to fat reduction and cellulite reduction, with two technologies in one platform.

Technavio has announced its latest market research report titled global optical biometry devices market 2019-2023.

Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of PolarityTE, Inc.

INTELLiSTEM Technologies, a Canadian biotech company revolutionizing stem cell medicine, is pleased to announce the establishment of a partnership with MÉDIMABS Inc.